Bluesight introduces new Shortage Risk flags within CostCheck, a drug procurement optimization tool for hospitals and health systems. The feature embeds Bluesight’s predictive drug shortage insights directly into workflows that can help reduce costs, showing low, medium, or high shortage risk indicators for specific NDCs, with forecasts extending up to 90 days ahead of traditional industry alerts. It represents an integration between ShortageCheck and CostCheck. Early visibility helps organizations balance savings opportunities with supply stability, reduce emergency purchasing and downstream rework, and make more consistent procurement decisions. CostCheck can help hospitals save on drug spend while supporting a more resilient procurement strategy.